BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8390422)

  • 1. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.
    Foo ML; Gunderson LL; Nagorney DM; McLlrath DC; van Heerden JA; Robinow JS; Kvols LK; Garton GR; Martenson JA; Cha SS
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):483-9. PubMed ID: 8390422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure.
    Paulino AC
    Am J Clin Oncol; 1999 Oct; 22(5):489-94. PubMed ID: 10521065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study.
    Bosset JF; Pavy JJ; Gillet M; Mantion G; Pelissier E; Schraub S
    Radiother Oncol; 1992 Jul; 24(3):191-4. PubMed ID: 1357725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
    Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
    Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the body and tail of the pancreas: is there room for adjuvant radiotherapy?
    Coquard R; Ayzac L; Romestaing P; Ardiet JM; Sentenac I; Gilly FN; Braillon G; Gérard JP
    Tumori; 1997; 83(4):740-2. PubMed ID: 9349313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.
    Willett CG; Lewandrowski K; Warshaw AL; Efird J; Compton CC
    Ann Surg; 1993 Feb; 217(2):144-8. PubMed ID: 8094952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma.
    Imamura M; Hosotani R; Kogire M
    Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
    Hsu CC; Herman JM; Corsini MM; Winter JM; Callister MD; Haddock MG; Cameron JL; Pawlik TM; Schulick RD; Wolfgang CL; Laheru DA; Farnell MB; Swartz MJ; Gunderson LL; Miller RC
    Ann Surg Oncol; 2010 Apr; 17(4):981-90. PubMed ID: 20087786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas.
    Redmond KJ; Wolfgang CL; Sugar EA; Ahn J; Nathan H; Laheru D; Edil BH; Choti MA; Pawlik TM; Hruban RH; Cameron JL; Herman JM
    Ann Surg Oncol; 2010 Dec; 17(12):3112-9. PubMed ID: 20680697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
    Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
    Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC; Klimstra DS; Brennan MF
    Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.